What Is Type 3 Diabetes? Insulin Resistance In The Brain That Could Trigger Alzheimer’s
Most people are aware of type 1 and type 2 diabetes, but did you know there is a type 3 diabetes as well! It is a more obscure term. Although it is not an accepted medical diagnosis, type 3 diabetes has been discussed in the literature as a possible relationship between insulin resistance in the brain and Alzheimer's disease. This link has been described to help explain how metabolic disorders impact brain health, causing cognitive decline and dementia.
Type 3 diabetes is more of a misnomer because it should not be confused with type 3c diabetes, which relates to pancreatic dysfunction. The term "type 3 diabetes," on the other hand, has been loosely used by some scientists to analogously propose that Alzheimer's disease is strongly implicated with insulin resistance in the brain.
This concept was conceptualized by Dr. Suzanne de la Monte and Dr. Jack Wands of Brown University in the year 2008. This hypothesis postulated that Alzheimer's disease may be called type 3 diabetes for it bears many similarities with glucose metabolism disorder type 2 diabetes. Their concept arises from the basic principle that insulin is fundamental to blood sugar regulation, but it is also the case with the brain. When brain cells become insulin-resistant, they lose access to glucose, impairing their function.
Research published in the Journal of Diabetes Science and Technology supports this hypothesis by indicating that insulin resistance can be a significant contributor to the occurrence of dementia, also referred to as Alzheimer's. The symptoms of memory loss and diminished reasoning are associated with impaired glucose metabolism in the body, especially in the cerebral tissue.
Although type 3 diabetes is not a "medical term," its symptoms correlate well with Alzheimer's diseases that are known to reduce the ability to think in an efficient manner and bring down brain health. These signs are:
- Loss of memory, especially short-term.
- Poor judgment and judgment ability
- Failure in recognizing people or places familiar once.
- Failure in the process of reading, writing or processing numbers
- Anxiety, agitation, or mood changes.
- Disorganized thoughts or confusion
- Lack of impulse control
As the disease advances, patients may be afflicted with severe complications including an inability to swallow or control their bodily functions. In the final stages, most patients die from fatal complications such as aspiration pneumonia.
This may not be well understood with regards to type 3 diabetes, or the exact link between insulin resistance and Alzheimer's disease. Some identified contributing factors include the following:
Insulin acts as an important regulatory mechanism of brain functions such as memory and cognition. The reduction in insulin signaling may impair metabolism of brain cells, thus bringing about neurodegeneration.
These diseases show a strong relationship and those individuals diagnosed with type 2 diabetes have double chances of getting Alzheimer's. In the two, the main causes can be chronic inflammation, oxidative stress, and a defect in glucose metabolism.
Insulin resistance associated with obesity, stress, and an unhealthy diet is considered a cause that may increase the chances of Alzheimer's disease.
Researches in Frontiers in Neuroscience and The Lancet Neurology have also highlighted that drugs used for antidiabetic medication may be crucial for the prevention or at least slowing down the course of Alzheimer's.
In 2022, in a study in Pharmaceuticals, researchers studied biomarker uptake in brain regions implicated in the faulty uptake and metabolism of blood sugar in Alzheimer’s patients.
Emerging Therapies
Research into such treatments as intranasal insulin has also been promising. Intranasal delivery of insulin directly to the brain has been reported to enhance glucose uptake by brain cells, improve memory, and boost cognitive performance. While such clinical trials have been shown to be successful, additional research is needed for safety and efficacy.
Medications
For patients being aggressive or agitated, antipsychotic drugs may be prescribed; however, therapies such as cognitive rehabilitation as well as cognitive stimulation therapy serve to preserve memory and executive function.
Lifestyle Interventions
Diet, exercise, and stress management are critical in preventing and managing insulin resistance. A review in the Journal of Alzheimer's Disease also highlighted the benefits of Kirtan Kriya meditation, which can regulate genes involved in insulin and glucose metabolism, improve sleep, and reduce inflammation.
Although type 3 diabetes is not officially recognized, its connection to Alzheimer’s disease underscores the importance of proactive measures for brain health. Some prevention strategies include:
1. Healthy Diet
Consuming a balanced diet rich in antioxidants, whole grains, and healthy fats may support brain health.
2. Regular Exercise
Physical activity improves insulin sensitivity, reduces inflammation, and enhances overall metabolic health.
3. Stress Reduction
Mindfulness practices, including meditation, have been shown to lower stress levels, which can reduce the risk of cognitive decline.
The term type 3 diabetes brings out the complex relationship between metabolic disorders and brain health. Even though it is not a recognized medical condition, the concept emphasizes the crucial role of insulin in brain function and its possible contribution to Alzheimer's disease. Continued research will hopefully provide hope for therapies such as intranasal insulin and lifestyle modifications.
(Credit-Canva)
Pancreatic cancer is widely known as a "silent killer" because it doesn't usually cause pain or noticeable issues until it is very advanced and hard to treat. This is why doctors and researchers are always searching for earlier signs. Fortunately, new research has uncovered a possible warning sign that could help find the disease much sooner. Detecting this cancer early, when it is small and hasn't spread, gives patients the best chance for a successful recovery.
The statistics for pancreatic cancer show just how deadly it is. Even though it makes up a small percentage of all cancer cases (around 3%), it is responsible for a large number of cancer deaths (about 8%).
This high death rate happens because the cancer is often only found after it has already spread to other organs in the body. When cancer is found late, the chance of survival is very low—only about 3% to 16% of people live for five years or more. Because of these low survival rates, finding a dependable way to spot this cancer early is absolutely essential to saving more lives.
Researchers at Johns Hopkins University School of Medicine have discovered a promising sign that might point to early cancer: the pancreatic duct is enlarged. The pancreatic duct is basically a tube that carries the digestive juices out of the pancreas.
In their study, published in the journal Gastro Hep Advances, the research team found that if this duct is swollen or enlarged, it suggests a much higher risk of developing pancreatic cancer. This sign is particularly important for people who already have a high chance of getting the disease due to family history or genetics.
The researchers studied 641 people who were already considered to be at a high risk for pancreatic cancer, either because close family members (like parents or siblings) had it, or because they had specific genes that increase the danger.
Key Discovery: They found that 97 of these high-risk patients had this enlarged pancreatic duct.
Increased Odds: When they tracked these patients, they found that those with the duct enlargement were 2.6 times more likely to eventually get pancreatic cancer compared to the people without the enlargement. The danger was even greater if they had the enlarged duct and three or more fluid-filled sacs, called cysts, on their pancreas.
This discovery gives doctors a clear signal to take action. If a doctor sees an enlarged pancreatic duct on a medical scan—even if the scan was initially ordered for a different issue, like checking for kidney stones or general belly pain—they should immediately treat it as a warning sign.
The action taken would be to either perform very frequent and detailed imaging (scans) to watch the area closely, or in some cases, do surgery to remove the tissue concerned.
Dr. Canto pointed out that sometimes, the swelling in the duct is visible even before the cancerous mass itself is big enough to be clearly seen on a scan. This means doctors have a valuable new chance to step in earlier than ever before.
The research is not stopping here; the team’s next big project is to teach Artificial Intelligence (AI) how to look at pancreas scans. The goal is for the AI to analyze the images and make even more specific and accurate predictions about a person's risk of developing pancreatic cancer.
Credits: Canva
Most toothpaste commercials show a long, dramatic swirl covering the entire length of the toothbrush. But dentists say this is not only misleading, it could actually be harmful.
A video shared by Dr. Miles Madison, Beverly Hills Periodontist & Dental Implant Specialist, has sparked fresh debate on how much toothpaste is truly safe. Paired with expert insights and existing dental research, one message is clear: more toothpaste does not mean better cleaning.
According to Dr. Madison, almost 40% of people use an excessive amount of toothpaste, as shown by CDC findings. The amount typically seen in commercials? “That much is a hell no,” he says.
His guidance on the correct amount is straightforward:
Use only a smear, roughly the size of a grain of rice.
This tiny amount protects the teeth without overexposing children to fluoride, especially since young kids often swallow toothpaste instead of spitting it out.
Use a pea-sized amount no more.
This is enough to clean the teeth thoroughly without increasing health risks.
Children under eight have teeth and gums that are still developing. Overusing toothpaste, particularly fluoride-containing toothpaste, can trigger dental fluorosis, a condition caused by excess fluoride intake. This results in yellow or white spots, enamel damage, pits, and an increased risk of cavities.
Because children tend to swallow toothpaste, larger amounts can quickly push them into unsafe fluoride levels.
Even though adults are less likely to swallow toothpaste, using too much can still:
Dentists also warn that people often rely too heavily on toothpaste while neglecting brushing technique — gentle circular motions, not force, and flossing.
However, its benefits peak at a pea-size amount. Beyond that, the risks outweigh the rewards.
Used correctly, toothpaste prevents cavities, gum disease, and tooth loss, but used excessively, it can do more harm than good.

(Credit-Canva)
Highlighting the importance of getting screened, surgeon Christine Lai reveals a key stage of breast cancer that most people do not know about.
Breast cancer is one of the leading cancer diagnoses for women throughout the world. But it is also a highly treatable type of cancer if found early. While most of us know that breast cancer symptoms like lumps in the breast or discharge from the nipples, these symptoms come when the cancer is already progressing to an advanced stage.
The University of Kansas Cancer Center explains that there could be a palpable lump or tenderness, but generally breast cancer has no symptoms in the early stage. But is this stage 1, or stage 2? Which early stage cannot be accurately diagnosed with self-examination.
In a recent post, Dr Christine Lai, Specialist Surgeon based in Australia, details the key stage people do not know about and its not 1 or 2, its stage 0.
Dr Lai explains that stage 0 is the very first and most treatable stage of breast cancer. At this point, no actual lump has formed, and the person usually has no symptoms.
The cancer cells are only sitting inside the milk ducts, where they are growing but have not yet developed the ability to break out and spread into the surrounding breast tissue.
This specific type of cancer is often called Ductal Carcinoma In Situ (DCIS). If we find cancer at this stage, it is almost certainly curable. This is why getting a routine screening mammogram is so crucial—it can catch this hidden stage and save a life.
In the video, Dr Lai details how big the tumor is during each stage, and how is it different from the previous stage, along with their treatability.
Stage 1 cancer means the tumor is quite small and is mostly confined to the breast. The tumor is usually 2 cm or less in size, which is smaller than a cherry. At this point, the cancer either hasn't spread to the lymph nodes at all, or the spread is extremely minimal and only visible under a microscope. Because the cancer is so small and localized, Stage 1 is highly treatable.
Stage 2 means the cancer is either moderately sized or has started to involve a few nearby lymph nodes. This stage applies if the tumor is smaller than 5 cm but has spread to up to three lymph nodes. It also applies if the tumor is larger than 5 cm but hasn't yet spread to any lymph nodes at all. Think of this as the cancer becoming more established, either by growing larger in one spot or starting to spread slightly to the closest glands.
Stage 3 indicates that the cancer has become more aggressive locally, involving more lymph nodes or invading nearby tissues. This applies if there are more than three involved lymph nodes, or if the tumor is invading the chest wall or the skin of the breast. A special type of cancer called inflammatory breast cancer is also classified as Stage 3 because of how it spreads across the breast tissue. This stage requires more intensive treatment because the disease has spread more extensively in the chest area.
Stage 4 is when the breast cancer has spread from the breast and armpit to distant parts of the body, such as the bones, lungs, liver, or brain. This is also known as metastatic breast cancer. While this stage is generally not curable, it is still highly treatable. Treatment focuses on controlling the cancer, relieving symptoms, and allowing the patient to maintain the best possible quality of life.
© 2024 Bennett, Coleman & Company Limited